Buy Dabibrook 110 mg (Dabigatran) – Effective Anticoagulant for Stroke & Clot Prevention

Dabibrook 110 mg contains dabigatran etexilate, a direct thrombin inhibitor used to prevent strokes and systemic embolism in non-valvular atrial fibrillation, and to treat or prevent deep vein thrombosis (DVT) and pulmonary embolism (PE). Manufactured by Healing Pharma (India), it’s shipped worldwide under prescription. 

How It Works

Dabigatran directly blocks thrombin to inhibit clot formation and ease fibrinolysis—reducing risk of stroke or clot recurrence without the need for regular INR monitoring like warfarin. 

Uses & Benefits

• Stroke/systemic embolism prevention in adults with non‑valvular atrial fibrillation. 
• Treatment and prevention of DVT and PE, including post‑arthroplasty prophylaxis. 
• Compared to warfarin, lowers intracranial bleeding risk—though gastrointestinal bleeding risk may be higher. 

Dosage & Administration

• Common adult dose: 110 mg twice daily for stroke prevention in AFib. 
• For DVT/PE: 110–150 mg twice daily depending on protocol or renal function. 
• Swallow capsules whole with water, with or without food. Consistency in timing is key. 
• Do not stop medication abruptly—doing so increases risk of stroke or clots. 

Side Effects & Safety

• Common: gastrointestinal upset (indigestion, nausea, diarrhea), dyspepsia, abdominal pain. 
• Major risk: bleeding—bruises, nosebleeds, red or tarry stool/urine, heavy menstrual bleeding. 
• Rare but critical: spinal or epidural hematoma—particularly with spinal procedures or NSAIDs. Watch for back pain or limb numbness. 
• Monitor for allergic reactions or esophageal mucosal injury in at-risk patients. 

Precautions & Drug Interactions

• Contraindicated in active bleeding, severe liver disease, mechanical heart valves. 
• Use caution in renal impairment—dose adjustments required; avoid My name: dabigatran monitors.
• Avoid concomitant NSAIDs, antiplatelets, or other anticoagulants due to increased bleeding risk. 
• If emergency surgery or bleeding occurs: idarucizumab (Praxbind) is the specific reversal agent. 
• Avoid alcohol—may worsen bleeding; avoid risky activities if dizziness or fatigue occur. 

Global Availability & Prescription Info

Dabibrook 110 mg is prescription-only and available internationally through licensed pharmacies. Requires clinician supervision, especially for renal function and bleeding risk. Manufactured by Healing Pharma (India). 

📌 Frequently Asked Questions (FAQs)

1. What is Dabibrook 110 mg used for?

It treats and prevents blood clots in conditions like atrial fibrillation, DVT, pulmonary embolism, and following hip/knee surgery.

2. When will I feel or see effects?

Anticoagulant effect begins within hours; though prevention benefits accrue with regular use. 

3. What side effects should I expect?

Stomach upset, dyspepsia and bleeding signs are possible. Report any unexplained bruising, blood in stool/urine, or severe GI discomfort.

4. Can I stop taking Dabibrook suddenly?

No—abrupt stopping may sharply increase risk of clot formation. Always consult your physician before discontinuing.

5. How is bleeding managed if it occurs?

If bleeding is serious, doctors can use idarucizumab (Praxbind) to reverse dabigatran’s effect immediately.